Pills, medicines
News Article
Drugmakers continue their efforts to offer end-to-end treatment options for COVID-19 patients.
David Kersenobich
Expert Contributor
David Kershenobich
Director General
Salvador Zubirán National Institute of Health Sciences and Nutrition
One of the most significant advances in the recent history of viral diseases is the development of innovative treatments for Patients with Hepatitis C
Juan Silanes CEO of Inosan Biopharma
View from the Top
Juan Silanes
Inosan Biopharma
Through a technology-based platform, Inosan is able to develop antibody, antiviral and antirabies solutions to address neglected health issues.
Subscribe to antiviral solutions